Țară: Australia
Limbă: engleză
Sursă: Department of Health (Therapeutic Goods Administration)
linezolid, Quantity: 600 mg
Cipla Australia Pty Ltd
Linezolid
Tablet, film coated
Excipient Ingredients: maize starch; hyprolose; sodium starch glycollate type A; magnesium stearate; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000
Oral
20, 100
(S4) Prescription Only Medicine
LINEZOLID CIP is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,LINEZOLID CIP is active against Gram-positive bacteria only.,LINEZOLID CIP has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.
Visual Identification: White to off-white, oval shaped, biconvex, film-coated tablets, debossed on one side "CL".; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-01-24